Dwg: Article written and Venn diagram created.

2026-02-27T10:23:35Z

Article written and Venn diagram created.

New page

== Comparison of alprazolam and lorazepam ==

Alprazolam and lorazepam are medications in the [[benzodiazepine]] class. Both drugs act as positive allosteric modulators of the [[GABAA receptor|gamma-aminobutyric acid (GABA)<sub>A</sub> receptor]] in the [[central nervous system]], which produces sedative, anxiolytic, and anticonvulsant effects. While they share a similar mechanism of action, they are distinguished by their [[pharmacokinetics]], approved medical uses, and metabolic pathways.

=== Comparison table ===

{| class="wikitable"
|-
! Feature !! Alprazolam !! Lorazepam
|-
| Common brand name || Xanax || Ativan
|-
| Primary indications || [[Panic disorder]], [[generalized anxiety disorder]] || Anxiety, [[status epilepticus]], surgical premedication
|-
| Equivalent dose || 0.5 mg || 1 mg
|-
| Time to peak plasma level || 1–2 hours || 2 hours
|-
| Mean elimination half-life || 11.2 hours || 10–20 hours
|-
| Primary metabolic pathway || Hepatic [[oxidation]] (CYP3A4) || Hepatic [[glucuronidation]]
|-
| Active metabolites || Alpha-hydroxyalprazolam (minimal activity) || None
|-
| Route of administration || Oral (tablet, liquid) || Oral, intramuscular, intravenous
|}

[[File:Venn_diagram_Differences_between_Alprazolam-_versus_Lorazepam_comparison.png|thumb|center|800px|alt=Venn diagram for Differences between Alprazolam- and Lorazepam|Venn diagram comparing Differences between Alprazolam- and Lorazepam]]

=== Pharmacokinetics and metabolism ===

The primary difference between alprazolam and lorazepam lies in their metabolic processing. Alprazolam is metabolized in the liver through oxidative pathways, specifically involving the [[cytochrome P450]] 3A4 (CYP3A4) enzyme. This makes alprazolam susceptible to drug-drug interactions with CYP3A4 inhibitors, such as [[ketoconazole]], [[clarithromycin]], and [[grapefruit juice]], which can increase alprazolam concentrations to potentially toxic levels.

In contrast, lorazepam is metabolized through glucuronidation, a process that bypasses the oxidative stage of metabolism. Because it does not rely on the cytochrome P450 system and does not produce active metabolites, lorazepam is often preferred for patients with impaired liver function or elderly patients who may have reduced oxidative capacity.

=== Clinical applications ===

Alprazolam is frequently used for the short-term management of panic disorder, with or without [[agoraphobia]], due to its relatively rapid onset. It is available in immediate-release and extended-release formulations.

Lorazepam has a broader range of clinical applications. It is used as a first-line treatment for status epilepticus (prolonged seizures) because of its effectiveness when administered intravenously and its tendency to remain in the brain longer than [[diazepam]]. It is also used in hospital settings as a sedative before anesthesia or for the management of [[alcohol withdrawal syndrome]].

=== Side effects and risks ===

Both medications carry risks of physical and psychological dependence. Common side effects for both include somnolence, dizziness, and motor incoordination. Rapid cessation of either drug after long-term use can result in severe [[benzodiazepine withdrawal syndrome|withdrawal symptoms]], including tremors, insomnia, and seizures. Alprazolam is often associated with a higher risk of "rebound anxiety" between doses due to its slightly shorter half-life and higher relative potency.

== References ==

<references>
<ref name="FDA-Xanax">{{cite web |title=Xanax (Alprazolam) Tablets Prescribing Information |url=https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018276s045lbl.pdf |publisher=U.S. Food and Drug Administration |access-date=February 27, 2026}}</ref>

<ref name="FDA-Ativan">{{cite web |title=Ativan (Lorazepam) Tablets Prescribing Information |url=https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017794s044lbl.pdf |publisher=U.S. Food and Drug Administration |access-date=February 27, 2026}}</ref>

<ref name="Griffin2013">{{cite journal |last1=Griffin |first1=CE |last2=Kaye |first2=AM |last3=Bueno |first3=FR |last4=Kaye |first4=AD |title=Benzodiazepine pharmacology and central nervous system-mediated effects |journal=The Ochsner Journal |date=2013 |volume=13 |issue=2 |pages=214–223 |pmid=23789008 |pmc=3684331}}</ref>

<ref name="Verster2004">{{cite journal |last1=Verster |first1=JC |last2=Volkerts |first2=ER |title=Clinical pharmacology, therapeutic efficacy, and safety of alprazolam |journal=CNS Drug Reviews |date=2004 |volume=10 |issue=1 |pages=45–76 |doi=10.1111/j.1527-3458.2004.tb00003.x |pmid=14978513}}</ref>
</references>

[[Category:Comparisons]]

Differences between Alprazolam- and Lorazepam - Revision history

Dwg: Article written and Venn diagram created.